In this instance, high H2AFJ expression had no significant effect on the survival of basal-like or luminal-B breast cancers, but was correlated with slightly better survival of HER2+ and normal-like breast cancer, and correlated with worse survival of luminal-A type breast cancers. The gene discussed is ERBB2; the disease is breast cancer.